The bioactive compounds alpha-chaconine and gallic acid in potato extracts decrease survival and induce apoptosis in

Lavanya Reddivari1, Jairam Vanamala, Stephen H Safe

  • 1Colorado State University, Fort Collins, Colorado, USA.

Nutrition and Cancer
|June 25, 2010
PubMed

Insights

Potato compounds alpha-chaconine and gallic acid show potent anti-prostate cancer effects. These bioactive molecules suppress cancer cell growth and induce apoptosis through multiple pathways, offering potential therapeutic strategies.

Area of Science:

  • Phytochemistry
  • Cancer Biology
  • Molecular Pharmacology

Background:

  • Colored potato extracts demonstrate anti-cancer properties against prostate cancer cell lines.
  • Key bioactive compounds responsible for these effects are being identified.

Purpose of the Study:

  • To identify major bioactive components in potato extracts.
  • To investigate the anti-proliferative and apoptosis-inducing effects of these components on prostate cancer cells (LNCaP and PC-3).

Main Methods:

  • Identification of bioactive potato components including chlorogenic acid, gallic acid, catechin, malvidin, alpha-chaconine, and solanine.
  • Assay of antiproliferative effects and apoptosis induction.
  • Analysis of caspase-dependent and independent pathways, including JNK and mitogen-activated protein kinase signaling.

Main Results:

  • Alpha-chaconine and gallic acid demonstrated potent antiproliferative activity and increased p27 levels in LNCaP and PC-3 cells.
  • Both compounds induced caspase-dependent apoptosis in LNCaP cells and caspase-independent apoptosis in both cell lines.
  • Alpha-chaconine and gallic acid activated JNK, crucial for caspase-dependent apoptosis.

Conclusions:

  • Alpha-chaconine and gallic acid are key contributors to the anti-prostate cancer effects of potato extracts.
  • These compounds induce apoptosis via both caspase-dependent and independent mechanisms.
  • The findings suggest potential therapeutic applications of these potato-derived compounds in prostate cancer treatment.